The global honey dressing market size is anticipated to reach USD 47.07 million by 2030, growing at a CAGR of 4.91% from 2024 to 2030. The market is significantly driven by the increasing prevalence of chronic wounds and the growing awareness of the therapeutic benefits of honey in wound care. Chronic wounds, such as diabetic ulcers, venous leg ulcers, and pressure sores are becoming more common due to factors such as an aging population and rising incidences of diabetes. For instance, in January 2024, as per the American Heart Association (AHA), there are 9.7 million adults with undiagnosed diabetes and 29.3 million with a diagnosis of diabetes.
The increasing preference for natural and organic products among healthcare professionals and patients is a significant driver of the market. Honey has been recognized for its antimicrobial properties due to its high sugar content, low pH, and presence of hydrogen peroxide, making it effective against a wide range of pathogens. In March 2023, the International Wound Journal published a study that performed a meta-analysis to evaluate the impact of Honey Dressing (HD) on the treatment of Diabetic Foot Ulcers (DFU). It was found that the use of HD on DFUs resulted in a notably increased rate of wound healing and reduced the time needed for the wounds to heal, compared to the control group.
The COVID-19 pandemic had a significant impact on the market. The pandemic caused interruptions in the global supply chain, affecting the production and distribution of honey dressings. Lockdowns, restrictions on movement, and reduced workforce availability led to delays in manufacturing and shipping. With heightened awareness of infection control during the pandemic, there was increased interest in wound care products with antimicrobial properties. Honey dressings, known for their antibacterial effects, have seen some increased attention in specific segments of the market focused on preventing wound infections. The economic downturn caused by the pandemic led to reduced healthcare budgets and lower consumer spending in some regions. This affected the overall market for wound care products, including honey dressings, as hospitals and individuals sought to cut costs.
Strick regulatory frameworks set by entities like the FDA in the U.S. and the EMA in Europe pose significant barriers to the honey dressing industry's expansion. These authorities demand rigorous evidence of efficacy and safety through detailed clinical testing and assessments for medical products, including those based on honey for treating wounds. The exhaustive and protracted nature of these regulatory processes can result in delayed market entry for new products and elevate production expenses, thus hampering the growth prospects of the honey dressing market. In June 2023, Medline Industries LP recalled TheraHoney Wound Gel following a sterilization dose audit failure reported by the manufacturer, who did not increase the dose post-failure in accordance with ISO 11137.
This product will be delivered within 1-3 business days.
The increasing preference for natural and organic products among healthcare professionals and patients is a significant driver of the market. Honey has been recognized for its antimicrobial properties due to its high sugar content, low pH, and presence of hydrogen peroxide, making it effective against a wide range of pathogens. In March 2023, the International Wound Journal published a study that performed a meta-analysis to evaluate the impact of Honey Dressing (HD) on the treatment of Diabetic Foot Ulcers (DFU). It was found that the use of HD on DFUs resulted in a notably increased rate of wound healing and reduced the time needed for the wounds to heal, compared to the control group.
The COVID-19 pandemic had a significant impact on the market. The pandemic caused interruptions in the global supply chain, affecting the production and distribution of honey dressings. Lockdowns, restrictions on movement, and reduced workforce availability led to delays in manufacturing and shipping. With heightened awareness of infection control during the pandemic, there was increased interest in wound care products with antimicrobial properties. Honey dressings, known for their antibacterial effects, have seen some increased attention in specific segments of the market focused on preventing wound infections. The economic downturn caused by the pandemic led to reduced healthcare budgets and lower consumer spending in some regions. This affected the overall market for wound care products, including honey dressings, as hospitals and individuals sought to cut costs.
Strick regulatory frameworks set by entities like the FDA in the U.S. and the EMA in Europe pose significant barriers to the honey dressing industry's expansion. These authorities demand rigorous evidence of efficacy and safety through detailed clinical testing and assessments for medical products, including those based on honey for treating wounds. The exhaustive and protracted nature of these regulatory processes can result in delayed market entry for new products and elevate production expenses, thus hampering the growth prospects of the honey dressing market. In June 2023, Medline Industries LP recalled TheraHoney Wound Gel following a sterilization dose audit failure reported by the manufacturer, who did not increase the dose post-failure in accordance with ISO 11137.
Honey Dressing Market Report Highlights
- Based on type, the non-adhesive segment held the largest revenue share in 2023 and is expected to grow at the highest CAGR from 2024 to 2030 due toits ability to promote wound healing through moisture retention and antibacterial properties, which help in reducing infection rates and enhancing tissue regeneration
- Based on product, the honey impregnated gauze segment dominated with a revenue share of 41.1% in 2023 due to its natural antibacterial properties, ability to promote moist wound healing, and its effectiveness in managing chronic wounds
- The honey gel sheets segment is expected to grow at the fastest CAGR from 2024 to 2030 owing to the convenient application method they provide while maintaining a moist environment conducive to healing
- Based on wound type, the chronic wounds segment held the largest revenue share in 2023 and is expected to grow at the highest CAGR from 2024 to 2030 due to the rising incidence of chronic wounds, associated with aging populations and conditions such as diabetes
- Based on end-use, the hospital segment dominated with a revenue share in 2023 due to their adoption of innovative wound care solutions to improve patient outcomes. The integration of honey-based dressings into hospital protocols reflects a shift towards evidence-based practices that prioritize effective wound management strategies
- The clinics segment is expected to grow at the fastest CAGR over the forecast period owing to their crucial role in the distribution and application of honey dressings for outpatient care
- North America dominated the market and accounted for a 42.3% share in 2023. The market is significantly influenced by the increasing awareness of natural and alternative therapies for wound care
The leading players in the Honey Dressing market include:
- Comvita
- INTEGRA LIFESCIENCES
- Advancis Medical
- ManukaMed Ltd.
- Medline Industries, LP.
- Medline Industries, LP.
- Kastormed
- Cardinal Health
- HoffenCare Medical Inc
- Polyx Inc
- Dynarex Corporation
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Honey Dressing Market Variables, Trends & Scope
Chapter 4. Honey Dressing Market: Type Estimates & Trend Analysis
Chapter 5. Honey Dressing Market: Product Estimates & Trend Analysis
Chapter 6. Honey Dressing Market: Wound Type Estimates & Trend Analysis
Chapter 7. Honey Dressing Market: End Use Estimates & Trend Analysis
Chapter 8. Honey Dressing Market: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players in the Honey Dressing market include:- Comvita
- INTEGRA LIFESCIENCES
- Advancis Medical
- ManukaMed Ltd.
- Medline Industries, LP.
- Medline Industries, LP.
- Kastormed
- Cardinal Health
- HoffenCare Medical Inc
- Polyx Inc
- Dynarex Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 33.72 Million |
| Forecasted Market Value ( USD | $ 47.07 Million |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
